[PERSON]
Silvio Garattini
Featured in 8 tracked stories · first seen
Situations
GLP-1 drugs: clinical trends, safety, and market shifts
326 clusters · 1181 sources · last updated
Latest: GLP-1 medication usage impacts nutrition trends and various business sectors
The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Recent findings presented at
Longevity and healthy aging research
26 clusters · 77 sources · last updated
Latest: Social engagement linked to improved cognitive health in elderly
Scientific research into longevity increasingly emphasizes the impact of lifestyle and environmental factors over genetics. Studies indicate that genes may account for only 6% to 50% of life expectancy variability, while
Silvio Garattini health and longevity advice
2 clusters · 5 sources · last updated
Latest: Silvio Garattini shares longevity advice as he nears 98
Silvio Garattini, the founder and president of the Mario Negri Institute, has shared various perspectives on health, cancer prevention, and longevity. Garattini has issued warnings regarding the carcinogenic nature of
Italian pharmaceutical spending and supply chain stability
3 clusters · 38 sources · last updated
Latest: Italian pharmaceutical spending reaches €6.78 billion in Q1 2026
The Italian Medicines Agency (AIFA) has released reports detailing fiscal and structural challenges within the national pharmaceutical sector. Earlier monitoring from early 2026 revealed a significant spending deficit in
Also covered in
-
Silvio Garattini and Valentino Gardi release new book on addiction
[HEALTH] · 2 sources ·